Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D plus chemotherapy versus chemotherapy alone after ovarian cancer surgery
IRCT2017101833680N4Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of vitamin d in Ovarian Epithelial Adenocarcinoma (2 arms), sponsored by Mashhad University of Medical Sciences. Started Mar 2018; status: completed.
02
Drugs
vitamin d
03
Conditions
Ovarian Epithelial Adenocarcinoma
Beyond the preview
Go deeper on IRCT2017101833680N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017101833680N4.